Skip to main content Skip to accessibility
This website is not compatible with your web browser. You should install a newer browser. If you live in Jersey and need help upgrading call the States of Jersey web team on 440099.
Government of Jerseygov.je

Information and public services for the Island of Jersey

L'înformâtion et les sèrvices publyis pouor I'Île dé Jèrri

Changes to be made to the Prescribed List (Jersey) as at 1 January 2009.

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

  • demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision

  • providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made (05/12/2008) regarding: Changes to be made to the Prescribed List (Jersey) as at 1 January 2009.

Decision Reference: MD-S-2008-0087

Decision Summary Title :

Prescribed List (Jersey) 1 January 2009

Date of Decision Summary:

18 November 2008

Decision Summary Author:

Rosie Goulding

Policy Principal

Decision Summary:

Public or Exempt?

Public

Type of Report:

Oral or Written?

Written

Person Giving

Oral Report:

N/A

Written Report

Title :

Changes to be made to the Prescribed List (Jersey) as at 1 January 2009

Date of Written Report:

18 November 2008

Written Report Author:

Rosie Goulding

Policy Principal

Written Report :

Public or Exempt?

Public

Subject:

Changes to be made to the Prescribed List (Jersey) as at 1 January 2009

Decision(s): The Minister approved the changes to the Prescribed List (Jersey) as recommended by the Pharmaceutical Benefits Advisory Committee from the meeting held on the 11th November 2008.

To be included:

Dermol cream (brand name).  

Doublebase shower gel (brand name)

Aspirin e/c tablet 75mg (generic only)

Salbutamol m/r capsules (Ventmax SR) 4mg, 8mg (open order) 

Mycophenolic acid (Myfortic) tablet e/c 180mg, 360mg (brand name)

Potassium permanganate solution tablet 400mg (open order) 

Dexamethasone oral solution 2mg/5mL (open order)

Hydrocortisone inj 25mg/mL

Cabergoline tablet 1mg, 2mg, 4mg (generic only)

Reason(s) for Decision:

The Pharmaceutical Benefits Advisory Committee met on 11th November 2008 and provided the Minister with the recommended changes to the Prescribed List (Jersey), effective from 1 January 2009. The changes represent additional formulations of approved medicines to ensure that General Practitioners have the choice available to them of modern, safe and effective medicines.

Resource Implications:

The cost to the fund is an estimated £30, 000 per annum and the fund has sufficient resources.

Action required:

The Minister approved the recommendations made by the Pharmaceutical Benefits Advisory Committee

Signature: 

Position: 

Date Signed:

Date of Decision (If different from Date Signed):

Back to top
rating button